BCPEM
ACGN

Bain Capital Public Equity Management’s Aceragen Inc ACGN Stock Holding History

Bain Capital Public Equity Management’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,799
Closed -$4.82M – 104
2017
Q4 		$4.82M Buy
+16,799
New +$4.8M 0.35% 50

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Bain Capital Public Equity Management's ACGN Position: Q1 2018 in Review

Bain Capital Public Equity Management sold out of Aceragen Inc (ACGN) in Q1 2018, closing a stake of 16,799 shares — an estimated $4.82M sold.

Bain Capital Public Equity Management first reported a position in ACGN in Q4 2017 and held it in 1 quarter. The position peaked at $4.82M in Q4 2017. 107 funds tracked by Wall St. Rank hold ACGN as of Q1 2018.

  • Bain Capital Public Equity Management reported no remaining Aceragen Inc position as of Q1 2018 after selling out during the quarter.
  • Bain Capital Public Equity Management sold 16,799 Aceragen Inc shares in Q1 2018, an estimated $4.82M.
  • Bain Capital Public Equity Management first reported a position in Aceragen Inc in Q4 2017 and held it in 1 quarter.
  • Bain Capital Public Equity Management's Aceragen Inc position peaked at $4.82M in Q4 2017.
  • 107 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2018.

Based on Bain Capital Public Equity Management's 13F filing for Q1 2018, filed 15 May 2018.